The new insight could guide the development of future broad-spectrum therapeutics against influenza virus.
The new process from the Shen lab may save time and resources in the search for rare cancer-fighting molecules.
The new findings may be relevant for future studies of sleep apnea and SIDS.
The new funding to the Davis lab will support research into the genes and brain proteins that might be important targets for therapeutics against memory loss.
Scripps Florida's Hans Renata is working to apply creativity to chemistry in the search for new compounds against disease.